Truta Brindusa, Wohler Elizabeth, Sobreira Nara, Datta Lisa W, Brant Steven R
Steven R Brant, Division of Gastroenterology & Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD 21210, United States.
McKusick-Nathan Institute of Genetics, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States.
World J Gastrointest Pharmacol Ther. 2020 Sep 8;11(4):69-78. doi: 10.4292/wjgpt.v11.i4.69.
The existence of genetic anticipation has been long disputed in inflammatory bowel disease (IBD) in the absence of the explanatory mechanism.
To determine whether it was predictive of genetic anticipation, we evaluated telomere length in IBD. We hypothesized that multiplex IBD families exhibit a genetic defect impacting telomere maintenance mechanisms.
We studied three IBD families with multiple affected members in three successive generations. We determined telomere length (TL) in lymphocytes and granulocytes from peripheral blood of the affected members using flow cytometry and fluorescence in-situ hybridization (flow FISH). We also performed whole exome sequencing in the blood of all available family members and used PhenoDB to identify potential candidate gene variants with recessive or dominant modes of inheritance.
Out of twenty-four patients of European descent selected to participate in the study, eleven patients, eight parent-child pairs affected by IBD, were included in the genetic anticipation analysis. Median difference in age at diagnosis between two successive generations was 16.5 years, with earlier age at onset in the younger generations. In most of the affected members, the disease harbored similar gastrointestinal and extraintestinal involvement but was more aggressive among the younger generations. TL was not associated with earlier age at onset or more severe disease in members of successive generations affected by IBD. NOD2 gene mutations were present in the Crohn's disease patients of one family. However, no gene variants were identified as potential candidates for inheritance.
Telomere shortening appears unlikely to be involved in mechanisms of possible genetic anticipation in IBD. Further studies using a larger sample size are required to confirm or refute our findings.
在缺乏解释机制的情况下,炎症性肠病(IBD)中遗传早现的存在长期以来一直存在争议。
为了确定它是否能预测遗传早现,我们评估了IBD患者的端粒长度。我们假设多个IBD家族存在影响端粒维持机制的遗传缺陷。
我们研究了三个连续三代有多个患病成员的IBD家族。我们使用流式细胞术和荧光原位杂交(流式FISH)测定了患病成员外周血淋巴细胞和粒细胞中的端粒长度(TL)。我们还对所有可用家庭成员的血液进行了全外显子测序,并使用PhenoDB来识别具有隐性或显性遗传模式的潜在候选基因变异。
在被选中参与研究的24名欧洲血统患者中,11名患者,即8对受IBD影响的亲子对,被纳入遗传早现分析。连续两代人诊断时的年龄中位数差异为岁,年轻一代发病年龄更早。在大多数患病成员中,疾病具有相似的胃肠道和肠外受累情况,但在年轻一代中更具侵袭性。TL与受IBD影响的连续几代成员的发病年龄较早或疾病更严重无关。一个家族的克罗恩病患者中存在NOD2基因突变。然而,没有基因变异被确定为潜在的遗传候选者。
端粒缩短似乎不太可能参与IBD中可能的遗传早现机制。需要进一步使用更大样本量的研究来证实或反驳我们的发现。